Academic literature on the topic 'NovaSil'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'NovaSil.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "NovaSil"

1

Zychowski, Katherine E., Sarah E. Elmore, Kristal A. Rychlik, Hoai J. Ly, Felipe Pierezan, Anitha Isaiah, Jan S. Suchodolski, Aline Rodrigues Hoffmann, Amelia A. Romoser, and Timothy D. Phillips. "Mitigation of Colitis with NovaSil Clay Therapy." Digestive Diseases and Sciences 60, no. 2 (September 21, 2014): 382–92. http://dx.doi.org/10.1007/s10620-014-3360-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Afriyie-Gyawu, Evans, John Mackie, Bhagirathi Dash, Melinda Wiles, John Taylor, Henry Huebner, Lili Tang, Hongxia Guan, Jia-Sheng Wang, and Timothy Phillips. "Chronic toxicological evaluation of dietary NovaSil Clay in Sprague-Dawley rats." Food Additives and Contaminants 22, no. 3 (March 2005): 259–69. http://dx.doi.org/10.1080/02652030500110758.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Wang, J. S., H. Luo, M. Billam, Z. Wang, H. Guan, L. Tang, T. Goldston, et al. "Short-term safety evaluation of processed calcium montmorillonite clay (NovaSil) in humans." Food Additives and Contaminants 22, no. 3 (March 2005): 270–79. http://dx.doi.org/10.1080/02652030500111129.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Anyango, Gladys, Irene Kagera, Florence Mutua, Peter Kahenya, Florence Kyallo, Pauline Andang’o, Delia Grace, and Johanna F. Lindahl. "Effectiveness of Training and Use of Novasil Binder in Mitigating Aflatoxins in Cow Milk Produced in Smallholder Farms in Urban and Periurban Areas of Kenya." Toxins 13, no. 4 (April 15, 2021): 281. http://dx.doi.org/10.3390/toxins13040281.

Full text
Abstract:
Aflatoxins, which commonly contaminate animal feeds and human food, present a major public health challenge in sub-Saharan Africa. After ingestion by cows, aflatoxin B1 is metabolized to aflatoxin M1 (AFM1), some of which is excreted in milk. This study involved smallholder dairy farms in urban and periurban areas of Nairobi and Kisumu, Kenya. The objective was to determine the effectiveness of training and providing farmers with aflatoxin binder (NovaSil®) on AFM1 contamination in raw milk. A baseline survey was undertaken and 30 farmers whose milk had AFM1 levels above 20 ppt were randomly selected for inclusion in the study. Of these, 20 farmers were part of the intervention, and were given training on the usage of the NovaSil® binder, while 10 served as a control group. All farmers were visited biweekly for three months for interviews and milk samples were collected to measure the AFM1 levels. The AFM1 levels were quantified by enzyme linked immunosorbent assay. The NovaSil® binder significantly reduced AFM1 concentrations in the raw milk produced by the farmers in the intervention group over the duration of the study (p < 0.01). The control farms were more likely to have milk with AFM1 levels exceeding the regulatory limit of 50 ppt compared to the intervention farms (p < 0.001) (odds ratio = 6.5). The farmers in the intervention group perceived that there was an improvement in milk yield, and in cow health and appetite. These farmers also felt that the milk they sold, as well as the one they used at home, was safer. In conclusion, the use of binders by dairy farmers can be effective in reducing AFM1 in milk. Further research is needed to understand their effectiveness, especially when used in smallholder settings.
APA, Harvard, Vancouver, ISO, and other styles
5

Bailey, C. A., G. W. Latimer, A. C. Barr, W. L. Wigle, A. U. Haq, J. E. Balthrop, and L. F. Kubena. "Efficacy of Montmorillonite Clay (NovaSil PLUS) for Protecting Full-Term Broilers from Aflatoxicosis." Journal of Applied Poultry Research 15, no. 2 (July 2006): 198–206. http://dx.doi.org/10.1093/japr/15.2.198.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Phillips, Timothy D., Meichen Wang, Sarah E. Elmore, Sara Hearon, and Jia-Sheng Wang. "NovaSil Clay for the Protection of Humans and Animals from Aflatoxins and Other Contaminants." Clays and Clay Minerals 67, no. 1 (February 2019): 99–110. http://dx.doi.org/10.1007/s42860-019-0008-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Marroquín-Cardona, A., Y. Deng, J. F. Garcia-Mazcorro, N. M. Johnson, N. J. Mitchell, L. Tang, A. Robinson, J. F. Taylor, J. S. Wang, and T. D. Phillips. "Characterization and safety of uniform particle size NovaSil clay as a potential aflatoxin enterosorbent." Applied Clay Science 54, no. 3-4 (December 2011): 248–57. http://dx.doi.org/10.1016/j.clay.2011.09.009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Afriyie-Gyawu, E., N. A. Ankrah, H. J. Huebner, M. Ofosuhene, J. Kumi, N. M. Johnson, L. Tang, et al. "NovaSil clay intervention in Ghanaians at high risk for aflatoxicosis. I. Study design and clinical outcomes." Food Additives & Contaminants: Part A 25, no. 1 (November 29, 2007): 76–87. http://dx.doi.org/10.1080/02652030701458105.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Wang, P., E. Afriyie-gyawu, Y. Tang, N. M. Johnson, L. Xu, L. Tang, H. J. Huebner, et al. "NovaSil clay intervention in Ghanaians at high risk for aflatoxicosis: II. Reduction in biomarkers of aflatoxin exposure in blood and urine." Food Additives & Contaminants: Part A 25, no. 5 (May 2008): 622–34. http://dx.doi.org/10.1080/02652030701598694.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Zychowski, Katherine, Aline Hoffmann, Hoai Ly, Camilo Pohlenz, Alejandro Buentello, Amelia Romoser, Delbert Gatlin, and Timothy Phillips. "The Effect of Aflatoxin-B1 on Red Drum (Sciaenops ocellatus) and Assessment of Dietary Supplementation of NovaSil for the Prevention of Aflatoxicosis." Toxins 5, no. 9 (September 16, 2013): 1555–73. http://dx.doi.org/10.3390/toxins5091555.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "NovaSil"

1

Afriyie-Gyawu, Evans. "Safety and efficacy of NovaSil clay as a dietary supplement to prevent aflatoxicosis." Texas A&M University, 2004. http://hdl.handle.net/1969.1/3192.

Full text
Abstract:
It is well documented that aflatoxin contamination in foods presents significant economic and public health burdens worldwide. Aflatoxins, particularly aflatoxin B1 (AFB1), have been implicated in the etiology of disease and death in many parts of the world, necessitating research initiatives for intervention strategies designed to diminish biological exposure. Calcium montmorillonite clays (e.g. NovaSil Plus, NSP) have been found to tightly bind and inactivate aflatoxins in the gastrointestinal tract of multiple animal species. In the future, the hypothesis is that this strategy may also be appropriate for humans. Thus, the overall research goal was to investigate NSP suitability for human use through in vitro characterization followed by in vivo evaluation of NSP-AFB1 sorption and most importantly, safety of the clay. The first objective was to characterize the in vitro and in vivo sorption efficiency of NSP-AFB1 sorption and determine potential interactions with vitamin A (VA). Isothermal analysis suggested that NSP binds AFB1 with high capacity, affinity, and specificity in aqueous solution and further indicated that NSP does not appear to interact with VA. Subsequent short-term studies in Sprague-Dawley (S-D) rats and broiler chicks indicated that dietary inclusion of NSP (0.25%) significantly reduced AFB1 bioavailability without exerting overt toxicity. The second objective was to evaluate potential adverse effects of chronic ingestion of dietary NSP using male and female S-D rats in the absence of aflatoxins. Although statistically significant changes to a few parameters were noted, the differences did not appear to be NSP- or dose-dependent, suggesting that NSP at dietary inclusion levels as great as 2.0% (w/w) does not produce overt toxicity. Thus, this information increases the feasibility for using NSP in human trials in populations at high risk for aflatoxicosis. The third objective was to establish representative baseline data on human exposure to aflatoxins by collecting and quantifying urinary AFM1 in volunteers living in four separate communities in Ejura district of Ghana. Results revealed that urinary AFM1 in the study population was substantially high (mean = 1,850.86 ± 274.59 pg/mg creatinine), indicating that this particular population was highly exposed to aflatoxins and could be used for future intervention trials.
APA, Harvard, Vancouver, ISO, and other styles
2

Liedtke, Ralf. "Das romantische Paradigma der Chemie : Friedrich von Hardenbergs Naturphilosophie zwischen Empirie und alchemistischer Spekulation /." Paderborn : Mentis, 2003. http://catalogue.bnf.fr/ark:/12148/cb390736651.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Vietor, Sophia. "Astralis von Novalis : Handschrift - Text - Werk /." Würzburg : Königshausen und Neumann, 2001. http://catalogue.bnf.fr/ark:/12148/cb40107879t.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hodkinson, James Richard. "Women and writing in the works of Novalis : transformation beyond measure ? /." Rochester (N.Y.) : Camden House, 2007. http://catalogue.bnf.fr/ark:/12148/cb41331988q.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Lohse, Nikolaus. "Dichtung und Theorie : der Entwurf einer dichterischen Transzendentalpoetik in den Fragmenten des Novalis /." Heidelberg : C. Winter, 1988. http://catalogue.bnf.fr/ark:/12148/cb34959791r.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kubik, Andreas. "Die Symboltheorie bei Novalis : eine ideengeschichtliche Studie in ästhetischer und theologischer Absicht /." Tübingen : Mohr Siebeck, 2006. http://catalogue.bnf.fr/ark:/12148/cb401807843.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Hu, Yihong. "Unterwegs zum Roman Novalis' Werdegang als Übergang von der Philosophie zur Poesie." Paderborn München Wien Zürich Schöningh, 2005. http://deposit.ddb.de/cgi-bin/dokserv?id=2800294&prov=M&dok_var=1&dok_ext=htm.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hartmann, Klaus. "Die Freiheitliche Sprachauffassung des Novalis /." Bonn : Bouvier Verl. H. Grundmann, 1987. http://catalogue.bnf.fr/ark:/12148/cb349834766.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Schefer, Olivier. "Novalis et le projet encyclopédique." Paris 10, 1998. http://www.theses.fr/1998PA100096.

Full text
Abstract:
Loin de << depasser >> l'entreprise kantienne pour elaborer un savoir absolu, il apparait que novalis ouvre d'emblee un dialogue avec l'idealisme naissant, en debordant le cadre pre-dialectique de la wissenschaftslehre de fichte pour une pensee de l'etre transcendant entee sur la subjectivite infinie. La philosophie de novalis se constitue comme l'investissement de l'espace des oppositions (sujet/objet, homme/nature). Aussi cette pensee pourrait-elle etre definie comme un savoir negatif de l'absolu. C'est a l'interieur de cette << docte ignorance romantique >> que la question de l'art, dans son lien avec la philosophie, se trouve posee. Le probleme majeur est ici de representer et d'ecrire la tension entre les contraires, et, en l'occurence de creer un symbole de l'inconnaissable. Le projet encyclopedique s'inscrit dans cette perspective pour la prolonger : en reprenant a son compte la combinatoire leibnizienne, novalis invente une ecriture metaphorique de la totalite. Le non-savoir romantique inaugure une reflexion, toujours actuelle, sur la crise de l'unite et son impossible representation. C'est du sein meme de la crise de la totalite que doit ici se rejouer l'unite. Il ressort du brouillon general que poesie et philosophie ont pour finalite la representation de la crise du savoir absolu, sous la forme d'une esthetique combinatoire. Dans sa recherche d'un symbole de la totalite inconnaissable, novalis accorde enfin une place decisive a la vie. S'ecartant du modele logique de la metaphysique, pour un modele organique, le corps du sujet devient un paradigme du tout. Le non-savoir et l'inachevement romantiques ont tout d'une ecriture du corps. Dans cette philosophie qui s'efforce d'articuler fragment et systeme, le corps emerge comme le symbole de l'absolu inconnaissable. La question que soulevent en definitive les fragments et l'esthetique du roman est la suivante : comment ecrire la vie, ou, comment dire le corps ?
APA, Harvard, Vancouver, ISO, and other styles
10

Struzek-Krähenbühl, Franziska. "Oszillation und Kristallisation Theorie der Sprache bei Novalis." Paderborn München Wien Zürich Schöningh, 2008. http://d-nb.info/994012756/04.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "NovaSil"

1

Jallet, Gilles. Novalis. Paris: Seghers, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Novalis. München: C.H. Beck, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Uerlings, Herbert, ed. Novalis. Berlin, New York: DE GRUYTER, 2004. http://dx.doi.org/10.1515/9783110928044.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Novalis. Paris: Félin, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Tavares, Gonçalo M. Investigações: Novalis. Algés: DIFEL, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Novalis: Biographie. München: C. Hanser, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Kraft, Gisela. Prolog zu Novalis. Berlin: Aufbau-Verlag, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Wanning, Berbeli. Novalis zur Einführung. Hamburg: Junius, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Sarfert, Hans-Jürgen. Novalis in Dresden. Dresden: Hellerau-Verlag, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Ebersbach, Volker. Novalis im liebeslabyrinth. Winsen: H. Boldt, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "NovaSil"

1

Koopmann, Helmut. "Novalis." In Kindler Kompakt: Deutsche Literatur, 19. Jahrhundert, 48–51. Stuttgart: J.B. Metzler, 2015. http://dx.doi.org/10.1007/978-3-476-05521-7_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Blödorn, Andreas. "Novalis." In Kindlers Literatur Lexikon (KLL), 1. Stuttgart: J.B. Metzler, 2020. http://dx.doi.org/10.1007/978-3-476-05728-0_12654-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Klotz, Volker. "Novalis." In Das europäische Kunstmärchen, 138–48. Stuttgart: J.B. Metzler, 1985. http://dx.doi.org/10.1007/978-3-476-03204-1_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Henschen, Hans-Horst, and Andreas Blödorn. "Novalis." In Kindler Kompakt: Reiseliteratur, 108–11. Stuttgart: J.B. Metzler, 2017. http://dx.doi.org/10.1007/978-3-476-04508-9_22.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Henschen, Hans-Horst, and Andreas Blödorn. "Novalis." In Kindler Kompakt: Märchen, 70–74. Stuttgart: J.B. Metzler, 2017. http://dx.doi.org/10.1007/978-3-476-04359-7_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Uerlings, Herbert. "Novalis, Novalis-Forschung und Wissenschaftsgeschichte." In Friedrich von Hardenberg, genannt Novalis, 1–14. Stuttgart: J.B. Metzler, 1991. http://dx.doi.org/10.1007/978-3-476-03377-2_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Grützmacher, Curt, and KLL. "Novalis: Fragmente." In Kindlers Literatur Lexikon (KLL), 1–3. Stuttgart: J.B. Metzler, 2020. http://dx.doi.org/10.1007/978-3-476-05728-0_12660-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Feger, Hans. "Novalis’ ordo inversus." In Poetische Vernunft, 301–36. Stuttgart: J.B. Metzler, 2007. http://dx.doi.org/10.1007/978-3-476-05259-9_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Blödorn, Andreas. "Novalis: Geistliche Lieder." In Kindlers Literatur Lexikon (KLL), 1–2. Stuttgart: J.B. Metzler, 2020. http://dx.doi.org/10.1007/978-3-476-05728-0_12656-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Ly, David, Christopher J. Anker, and Meic H. Schmidt. "Novalis Spinal Radiosurgery." In Tumors of the Central Nervous System, Volume 11, 223–36. Dordrecht: Springer Netherlands, 2013. http://dx.doi.org/10.1007/978-94-007-7037-9_20.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "NovaSil"

1

Bird, Rachel, Phil Whittaker, Kevin Hall, Caroline Slim, and Martin Cohen. "NovaSAR: Next generation developments." In 2015 IEEE 5th Asia-Pacific Conference on Synthetic Aperture Radar (APSAR). IEEE, 2015. http://dx.doi.org/10.1109/apsar.2015.7306163.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Iervolino, Pasquale, Raffaella Guida, and Philip Whittaker. "Novasar-S and maritime surveillance." In IGARSS 2013 - 2013 IEEE International Geoscience and Remote Sensing Symposium. IEEE, 2013. http://dx.doi.org/10.1109/igarss.2013.6723015.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Rossi, Cristian, Maral Bayaraa, Thomas Jones, Andrea Minchella, and Simon Agass. "The Novasar UK Background Mission." In IGARSS 2019 - 2019 IEEE International Geoscience and Remote Sensing Symposium. IEEE, 2019. http://dx.doi.org/10.1109/igarss.2019.8900238.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Couto, Maria de Fátima Morethy. "Novas leituras do modernismo." In Encontro da História da Arte. Universidade Estadual de Campinas, 2005. http://dx.doi.org/10.20396/eha.1.2005.3617.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Zhou, Zheng-Shu, Amy Parker, Laura Brindle, Ake Rosenqvist, Peter Caccetta, and Alex Held. "Initial NovaSAR-1 Data Processing and Imagery Evaluation." In IGARSS 2020 - 2020 IEEE International Geoscience and Remote Sensing Symposium. IEEE, 2020. http://dx.doi.org/10.1109/igarss39084.2020.9323291.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

"Microbiota e Obesidade: Novas Perspectivas." In XXI I Congresso Brasileiro de Nutrologia. Thieme Revinter Publicações Ltda, 2018. http://dx.doi.org/10.1055/s-0038-1674831.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Ribeiro, Deborah Helen Fabiano. "MALÁRIA: NOVAS PERSPECTIVAS DE PREVENÇÃO." In I Congresso Brasileiro de Parasitologia Humana On-line. Revista Multidisciplinar em Saúde, 2021. http://dx.doi.org/10.51161/rems/713.

Full text
Abstract:
Introdução: Em 2014 houve cerca de 214 milhões de casos de malária mundiais, com uma estimativa de 438.000 óbitos, muitos na África subsaariana. O Brasil, por seus aspectos climáticos, também sofre com a malária. Possuindo registros de programas de controle desde 1905, contextuando a durabilidade do problema. A espécie da malária com 84% dos casos nacionais é a Plasmodium vivax, diferente da maior parte do mundo que é lesada pela Plasmodium falciparum. O mosquito transmissor, do gênero Anopheles, costuma atacar em certos períodos do ano, introduzindo o parasita. Por esse fato, foi elaborada a quimioprevenção sazonal da malária (SMC), que se trata de medicamentos ministrados ao público com idade inferior aos 5 anos, o qual é o mais afetado, antes do pico de transmissão anual. O SMC, demonstrou resultados promissores com a redução de 82% dos casos no grupo. Entretanto, a aplicação dos fármacos é trabalhosa e no futuro podem acontecer casos de resistência medicamentosa, por isso são vitais novas tecnologias para conter a enfermidade. Objetivo: Discorrer acerca das novas perspectivas envolvendo a vacinação para a malária. Material e métodos: Se trata de uma revisão de literatura, com utilização da base de dados PubMed, com as palavras de busca: malaria; vaccination; brazil; Plasmodium vivax. E artigos pesquisados dos anos de 2010 a 2020. Resultados: Foram encontradas vacinas em desenvolvimento, a maior parte delas para o P. falciparum, com destaque ao modelo RTS,S/AS01, que demonstra uma alta eficácia, mas com baixa durabilidade. Outros protótipos com mecanismos divergentes também tiveram resultados positivos, fato que demonstra as possibilidades de combate ao parasita de maneiras diferentes. Já os estudos acerca da espécie P. vivax ainda surgem timidamente. Conclusão: a vacina se trata de uma possibilidade futura, mesmo com a necessidade de mais testes e metas de imunização. Se tratando de uma importante aliada ao combate da enfermidade já que imunizará mais camadas da população que o tratamento atual, além de ser capaz de auxiliar o tratamento SMS já existente, tornandoo mais eficaz.
APA, Harvard, Vancouver, ISO, and other styles
8

Liu, Fangming, Shijun Shen, Bo Li, Baochun Li, Hao Yin, and Sanli Li. "Novasky: Cinematic-quality VoD in a P2P storage cloud." In IEEE INFOCOM 2011 - IEEE Conference on Computer Communications. IEEE, 2011. http://dx.doi.org/10.1109/infcom.2011.5935320.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Jokinen, Altti, Cameron Ellum, Iain Webster, Surendran Shanmugam, and Kevin Sheridan. "NovAtel CORRECT with Precise Point Positioning (PPP): Recent Developments." In 31st International Technical Meeting of The Satellite Division of the Institute of Navigation (ION GNSS+ 2018). Institute of Navigation, 2018. http://dx.doi.org/10.33012/2018.15824.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Jokinen, Altti, Cameron Ellum, Iain Webster, and Sara Masterson. "NovAtel CORRECT with Precise Point Positioning (PPP): Recent Developments." In 29th International Technical Meeting of The Satellite Division of the Institute of Navigation (ION GNSS+ 2016). Institute of Navigation, 2016. http://dx.doi.org/10.33012/2016.14600.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "NovaSil"

1

Valero Sancho, JL, and A. Castañeda Zumeta. Nuevas narrativas visuales / Novas narrativas visuais. Revista Latina de Comunicación Social, November 2018. http://dx.doi.org/10.4185/cac150.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Rosen, Neal. Development of Targeted Ansamycins as Noval Antiestrogens and Tyrosine Kinase Inhibitors. Fort Belvoir, VA: Defense Technical Information Center, September 2000. http://dx.doi.org/10.21236/ada413599.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Nico, Bravo. Relatório Final do Projeto de Investigação “As Novas Núpcias da Qualificação no Alentejo”. Centro de Investigação em Educação e Psicologia da Universidade de Évora, 2013. http://dx.doi.org/10.5935/ref.20160088.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Nico, Bravo. Relatório Final do Projeto de Investigação “As Novas Núpcias da Qualificação no Alentejo”. Universidade de Évora, 2013. http://dx.doi.org/10.5935/ref.20160155.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Conklin, Douglas S. Functional Geonic Analysis of Breast Cancer Cell Tumorigenicity Using a Noval Gene Silencing Resource. Fort Belvoir, VA: Defense Technical Information Center, April 2007. http://dx.doi.org/10.21236/ada477002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Vlachos, Dion, and Nagesh Peela. Development of Noval Catalysts for Total Oxidation of Hydrocarbons and JP-8 at Low Temperature. Fort Belvoir, VA: Defense Technical Information Center, July 2014. http://dx.doi.org/10.21236/ada614553.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Conklin, Douglas S. Functional Geno,ic Analysis of Breast Cancer Cell Tumorigenicity Using a Noval Gene Silencing Resource. Fort Belvoir, VA: Defense Technical Information Center, April 2006. http://dx.doi.org/10.21236/ada467802.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Thompson, L. T., P. E. Savage, and D. E. Briggs. Noval catalysts for upgrading coal-derived liquids. Quarterly technical progress report, March 1, 1995--May 31, 1995. Office of Scientific and Technical Information (OSTI), December 1994. http://dx.doi.org/10.2172/172118.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Holland, Darren, and Nazmina Mahmoudzadeh. Foodborne Disease Estimates for the United Kingdom in 2018. Food Standards Agency, January 2020. http://dx.doi.org/10.46756/sci.fsa.squ824.

Full text
Abstract:
In February 2020 the FSA published two reports which produced new estimates of foodborne norovirus cases. These were the ‘Norovirus Attribution Study’ (NoVAS study) (O’Brien et al., 2020) and the accompanying internal FSA technical review ‘Technical Report: Review of Quantitative Risk Assessment of foodborne norovirus transmission’ (NoVAS model review), (Food Standards Agency, 2020). The NoVAS study produced a Quantitative Microbiological Risk Assessment model (QMRA) to estimate foodborne norovirus. The NoVAS model review considered the impact of using alternative assumptions and other data sources on these estimates. From these two pieces of work, a revised estimate of foodborne norovirus was produced. The FSA has therefore updated its estimates of annual foodborne disease to include these new results and also to take account of more recent data related to other pathogens. The estimates produced include: •Estimates of GP presentations and hospital admissions for foodbornenorovirus based on the new estimates of cases. The NoVAS study onlyproduced estimates for cases. •Estimates of foodborne cases, GP presentations and hospital admissions for12 other pathogens •Estimates of unattributed cases of foodborne disease •Estimates of total foodborne disease from all pathogens Previous estimates An FSA funded research project ‘The second study of infectious intestinal disease in the community’, published in 2012 and referred to as the IID2 study (Tam et al., 2012), estimated that there were 17 million cases of infectious intestinal disease (IID) in 2009. These include illness caused by all sources, not just food. Of these 17 million cases, around 40% (around 7 million) could be attributed to 13 known pathogens. These pathogens included norovirus. The remaining 60% of cases (equivalent to 10 million cases) were unattributed cases. These are cases where the causal pathogen is unknown. Reasons for this include the causal pathogen was not tested for, the test was not sensitive enough to detect the causal pathogen or the pathogen is unknown to science. A second project ‘Costed extension to the second study of infectious intestinal disease in the community’, published in 2014 and known as IID2 extension (Tam, Larose and O’Brien, 2014), estimated that there were 566,000 cases of foodborne disease per year caused by the same 13 known pathogens. Although a proportion of the unattributed cases would also be due to food, no estimate was provided for this in the IID2 extension. New estimates We estimate that there were 2.4 million cases of foodborne disease in the UK in 2018 (95% credible intervals 1.8 million to 3.1 million), with 222,000 GP presentations (95% Cred. Int. 150,000 to 322,000) and 16,400 hospital admissions (95% Cred. Int. 11,200 to 26,000). Of the estimated 2.4 million cases, 0.9 million (95% Cred. Int. 0.7 million to 1.2 million) were from the 13 known pathogens included in the IID2 extension and 1.4 million1 (95% Cred. Int. 1.0 million to 2.0 million) for unattributed cases. Norovirus was the pathogen with the largest estimate with 383,000 cases a year. However, this estimate is within the 95% credible interval for Campylobacter of 127,000 to 571,000. The pathogen with the next highest number of cases was Clostridium perfringens with 85,000 (95% Cred. Int. 32,000 to 225,000). While the methodology used in the NoVAS study does not lend itself to producing credible intervals for cases of norovirus, this does not mean that there is no uncertainty in these estimates. There were a number of parameters used in the NoVAS study which, while based on the best science currently available, were acknowledged to have uncertain values. Sensitivity analysis undertaken as part of the study showed that changes to the values of these parameters could make big differences to the overall estimates. Campylobacter was estimated to have the most GP presentations with 43,000 (95% Cred. Int. 19,000 to 76,000) followed by norovirus with 17,000 (95% Cred. Int. 11,000 to 26,000) and Clostridium perfringens with 13,000 (95% Cred. Int. 6,000 to 29,000). For hospital admissions Campylobacter was estimated to have 3,500 (95% Cred. Int. 1,400 to 7,600), followed by norovirus 2,200 (95% Cred. Int. 1,500 to 3,100) and Salmonella with 2,100 admissions (95% Cred. Int. 400 to 9,900). As many of these credible intervals overlap, any ranking needs to be undertaken with caution. While the estimates provided in this report are for 2018 the methodology described can be applied to future years.
APA, Harvard, Vancouver, ISO, and other styles
10

Krohling Kunsch, Margarida Maria. A formação universitária em Relações Públicas: novas demandas e desafios da sociedade contemporânea / The educational background in Public Relations: new demands and challenges of the contemporary society. Revista Internacional de Relaciones Públicas, December 2017. http://dx.doi.org/10.5783/rirp-14-2017-02-05-22.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography